This is a preview of subscription content, log in via an institution to check access.
Notes
2019 Australian dollars
Reference
To YH, et al. Circulating Tumour DNA as a Potential Cost-Effective Biomarker to Reduce Adjuvant Chemotherapy Overtreatment in Stage II Colorectal Cancer. . PharmacoEconomics : 5 Jun 2021. Available from: URL: http://doi.org/10.1007/s40273-021-01047-0
Rights and permissions
About this article
Cite this article
Circulating tumour-guided adjuvant chemotherapy may be cost effective for colorectal cancer. PharmacoEcon Outcomes News 881, 4 (2021). https://doi.org/10.1007/s40274-021-7800-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-7800-2